U.S. markets close in 7 minutes

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
465.75+9.40 (+2.06%)
At close: 3:30PM IST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in INR

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/29/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
1.11T1.13T845.29B1.04T934.42B
Enterprise Value 3
1.09T1.10T808.01B1.00T927.78B
Trailing P/E
153.4428.3721.1323.9831.23
Forward P/E 1
26.7425.1318.7322.0321.79
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
3.473.572.663.303.09
Price/Book (mrq)
2.462.621.952.392.26
Enterprise Value/Revenue 3
3.3914.479.8712.2711.42
Enterprise Value/EBITDA 6
30.94-67.0867.7651.0246.61

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 316.05%
S&P500 52-Week Change 37.93%
52 Week High 3564.75
52 Week Low 3312.00
50-Day Moving Average 3503.77
200-Day Moving Average 3492.02

Share Statistics

Avg Vol (3 month) 310.31M
Avg Vol (10 day) 36.68M
Shares Outstanding 52.4B
Float 1.03B
% Held by Insiders 156.16%
% Held by Institutions 124.28%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 46.75
Forward Annual Dividend Yield 41.48%
Trailing Annual Dividend Rate 34.00
Trailing Annual Dividend Yield 30.88%
5 Year Average Dividend Yield 40.53
Payout Ratio 4190.40%
Dividend Date 3N/A
Ex-Dividend Date 4Aug 19, 2020
Last Split Factor 22:1
Last Split Date 3Jul 29, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2020
Most Recent Quarter (mrq)Jun 30, 2020

Profitability

Profit Margin 2.25%
Operating Margin (ttm)14.80%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)320.48B
Revenue Per Share (ttm)133.57
Quarterly Revenue Growth (yoy)-9.40%
Gross Profit (ttm)231.58B
EBITDA 68.78B
Net Income Avi to Common (ttm)7.22B
Diluted EPS (ttm)3.01
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)123.14B
Total Cash Per Share (mrq)51.32
Total Debt (mrq)75.78B
Total Debt/Equity (mrq)15.43
Current Ratio (mrq)N/A
Book Value Per Share (mrq)189.05

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A